ITGAM and glioblastoma: To determine if derivatives of the STR‐MP CD11b+ cells can integrate and survive in a human brain environment, GFP+ stromal cultures consisting of, on average, 0.236% ± 0.109% GFP+ nonhematopoietic CD11b+ cells were grafted into ex vivo human brain tissue containing glioblastoma.